General Statement of Disclosure:

OTHER FINANCIAL BENEFIT: Daichii-Sankyo(MODEST), Roche Diagnostics(SIGNIFICANT), AstraZeneca(SIGNIFICANT), Sanofi(MODEST), Bayer(MODEST), Boehringer-Ingelheim(MODEST), Bristol-Myers Squibb(MODEST), Pfizer(MODEST), Novartis Corporation(MODEST)

View Full Disclosure